|Mr. Gerald E. Commissiong||CEO, Pres & Director||465.27k||N/A||1983|
|Mr. Daniel Hirsch||CFO & Director||315.27k||N/A||1969|
|Mr. Chris Gross||VP of Operations||N/A||N/A||N/A|
|Dr. Jorge A. Leon Ph.D.||Chief Science Officer||N/A||N/A||N/A|
|Dr. Paula T. Trzepacz M.D.||Chief Medical Officer of Neurology||N/A||N/A||N/A|
|Dr. Joseph Wee||Managing Director of Singapore||N/A||N/A||N/A|
|Ms. Ilanit Halperin CPA||Corp. Controller||N/A||N/A||1971|
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.
Todos Medical Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.